). This is something that would allow you to do the early assessment for your patient. Based on the FIB-4 score — and again, these are labs we typically have in primary care — you could assess them to be low risk for advancing to fibrosis, intermediate risk, or high risk.probably at low risk for a liver-related complication
As I'm listening to you, I'm thinking, wow, this is really great that we have a pathway like this. I'm also thinking that we always have to keep in mind that our pathways and guidelines are just guidelines, they're population based, they're structured to take care of large groups of people, and there are always going to be outliers.
If you have a person you think is at higher risk or they need the indeterminate or the high-risk score, you should do a second test. That second test is a. At least at the time of the writing in 2021, we had recommended a FibroScan because it is, again, a noninvasive tool that is ultrasound-based that allows you not only to look at the liver but also get an assessment of. Then you can see, again, three levels of stiffness associated with low risk, indeterminate risk, or high risk.
Entertainment Entertainment Latest News, Entertainment Entertainment Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: nypost - 🏆 91. / 67 Read more »
Source: 6abc - 🏆 250. / 63 Read more »